Insider Stock Trading History of D Alonzo Thomas


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider D Alonzo Thomas since year 2005. The trader's CIK number is 1212667. At the time of this reporting, D Alonzo Thomas is the Director of Salix Pharmaceuticals Ltd . (stock ticker symbol SLXP). See this page for all insider trading activities at Salix Pharmaceuticals Ltd .


Stock purchases, sales, and option exercises reported by insider D Alonzo Thomas since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-04-22 SLXP Salix Pharmaceuticals Ltd Sale 11,530 111.35 1,283,900
2014-01-10 SLXP Salix Pharmaceuticals Ltd Option Ex 22,500 18.87 424,575
2014-01-10 SLXP Salix Pharmaceuticals Ltd Sale 12,050 92.34 1,112,697
2013-04-08 SLXP Salix Pharmaceuticals Ltd Option Ex 15,000 7.60 114,000
2013-04-08 SLXP Salix Pharmaceuticals Ltd Sale 6,186 49.84 308,341
2012-06-08 SLXP Salix Pharmaceuticals Ltd Sale 9,550 51.63 493,066
2011-12-06 SLXP Salix Pharmaceuticals Ltd Option Ex 15,000 4.07 61,050
2011-12-06 SLXP Salix Pharmaceuticals Ltd Sale 4,700 44.43 208,821
2011-08-11 SLXP Salix Pharmaceuticals Ltd Buy 690 29.61 20,430
2010-12-01 SLXP Salix Pharmaceuticals Ltd Buy 500 44.80 22,399
2010-10-07 SLXP Salix Pharmaceuticals Ltd Buy 260 38.00 9,880
2009-05-13 SLXP Salix Pharmaceuticals Ltd Sale 7,500 9.48 71,092
2009-05-12 SLXP Salix Pharmaceuticals Ltd Sale 7,500 10.40 77,970
2009-05-13 SLXP Salix Pharmaceuticals Ltd Option Ex 7,500 4.92 36,900
2009-05-11 SLXP Salix Pharmaceuticals Ltd Sale 7,500 10.40 78,007
2009-05-12 SLXP Salix Pharmaceuticals Ltd Option Ex 7,500 4.92 36,900
2009-05-11 SLXP Salix Pharmaceuticals Ltd Option Ex 7,500 4.92 36,900
2007-07-03 SLXP Salix Pharmaceuticals Ltd Sale 3,129 12.31 38,517
2006-11-13 SLXP Salix Pharmaceuticals Ltd Sale 1,200 13.18 15,812
2006-05-08 SLXP Salix Pharmaceuticals Ltd Buy 6,900 13.02 89,803

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by D Alonzo Thomas (Director of Salix Pharmaceuticals Ltd at the time of this reporting) see the Securities and Exchange Commission (SEC) website.